EMA green light for new medicines
by Gary Finnegan: Five new medicines have been recommended for approval at the latest meeting of the European Medicines Agency’s Committee for Medicinal Products for Human Use
by Gary Finnegan: Five new medicines have been recommended for approval at the latest meeting of the European Medicines Agency’s Committee for Medicinal Products for Human Use
by Gary Finnegan: The European Medicines Agency (EMA) has reduced the fees it charges to companies who hold – or apply for – marketing authorisation for medicines.
by Gary Finnegan: Medicines watchdogs on both sides of the Atlantic could significantly step up collaboration if a new transatlantic trade deal is sewn up later this year.
by Bruce Sylvester: Researchers report that a combination morphine and nortriptyline successfully relieves chronic neuropathic pain in 87 per cent of patients, and the efficacy of the combination… read more.
by Bruce Sylvester: Researchers from a phase 3, randomized trial of brentuximab vedotin report that adults with hard-to-treat Hodgkin lymphoma treated with brentuximab vedotin immediately after stem cell… read more.
by Bruce Sylvester: Paracetamol is not effective for treating neck and lower back pain, and it provides only slight relief for osteoarthritis, researchers reported on March 31, 2015… read more.
by Bruce Slyvester: Among a large group of women who carry disease-associated mutations in BRCA1 or BRCA2 genes, genetic mutations appear to be associated with significantly different risks of developing breast… read more.
by Bruce Sylvester: A blood test administered between weeks 10 and 14 weeks of pregnancy appears to be a more accurate diagnostic tool for Down syndrome and two… read more.
by Bruce Sylvester: Diabetes and advanced stage breast cancer appear to be linked and diabetic women need better screening, Canadian researchers reported online on March 24, 2015 in… read more.
Experts are calling for a global review of guidelines used to diagnose sepsis, after a study found one in eight patients with infections severe enough to need admission… read more.
The first blood test for osteoarthritis could soon be developed, thanks to research by the University of Warwick. The research findings could potentially lead to patients being tested… read more.
A cancer drug could be made 50 times more effective by a chemical found in stinging nettles and ants, new research finds.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.